Advertisement

Topics

Latest "Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer" News Stories

23:59 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer" found in our extensive news archives from over 250 global news sources.

More Information about Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer for you to read. Along with our medical data and news we also list Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer Clinical Trials, which are updated daily. BioPortfolio also has a large database of Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer Companies for you to search.

Showing "Radiation Therapy With Without Carbogen Niacinamide Treating Patients" News Articles 1–25 of 27,000+

Monday 25th March 2019

[Articles] Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis

The effectiveness of sulfadoxine-pyrimethamine IPTp is reduced in areas with high resistance to sulfadoxine-pyrimethamine among P falciparum parasites, but remains associated with reductions in low birthweight even in areas where dhps Lys540Glu prevalence exceeds 90% but where the sextuple-mutant parasite (harbouring the additional dhps Ala581Gly mutation) is uncommon. Therapeutic alternatives to ...


Opinion: "Because of my coach, I feel more rooted to myself, patients and the practice of medicine and I will be a better physician because of it.” How coaching in med school can help prevent physician burnout. https://buff.ly/2TV1EYs 

Opinion: "Because of my coach, I feel more rooted to myself, patients and the practice of medicine and I will be a better physician because of it.” How coaching in med school can help prevent physician burnout. https://buff.ly/2TV1EYs 

bluebird bio Statement on European Regulatory Status of LentiGlobin™

A third party press release was issued today stating that the EMA (European Medicines Agency) issued an approval for the conditional Marketing Authorization Application (MAA) for LentiGlobin™, bluebird bio’s investigational gene therapy for the treatment of transfusion dependent β-thalassemia (TDT). LentiGlobin for TDT is scheduled to be reviewed as p...


OtiTopic Moves towards Its Clinical Phase with Dry Powder Inhalation of Aspirin to Reduce the Risk of Vascular Mortality in Patients with Suspected Acute Myocardial Infarction (Ml)

New England Journal of Medicine Study Reports Harmful Side Effects of Daily Aspirin Extensive studies on the effects of Aspirin on human health have been conducted over the past 100 years. Cardiovascular diseases are one of the top causes of death in America among older adults. For the past couple of decades, daily low dose aspirin has been a primary a...

Cannabics Pharma Developing Personalized Cannabinoid Therapies

The Investing News Network spoke with Eyal Barad, CEO of Cannabics Pharmaceuticals, about the company's approach to treating cancers. The post Cannabics Pharma Developing Personalized Cannabinoid Therapies appeared first on Investing News Network.

Digital health startups are scrambling to figure out how best to respond to patients who are confessing suicidal thoughts on apps that were only designed to help them manage things like diabetes or to figure out why they might have a headache. https://bu

Digital health startups are scrambling to figure out how best to respond to patients who are confessing suicidal thoughts on apps that were only designed to help them manage things like diabetes or to figure out why they might have a headache. https://buff.ly/2JGdkK1  pic.twitter.com/acaUFwdYrC

Litigation Resolved With $775M Settlement for Patients Prescribed Blood Thinner

Bayer Healthcare and Janssen Pharmaceuticals Inc., the makers of the Xarelto® (rivaroxaban), agreed to resolve approximately 25,000 state and federal claims about the drug with payment.

Topical Immunotherapy Keeps Skin Cancer Risk at Bay

NewsA combination of two topical creams lowers the risk that patients will later develop squamous cell carcinoma of the skin.Contributed Author: 

Say Good Bye to Meniere’s Disease—Here’s How to Make Your World Stop Spinning

Based on 1,000 one-week intensive care patients at Burcon Chiropractic Meniere's Research Institute, 97% reported dramatic improvement or elimination of vertigo after one year follow up. GRAND RAPIDS, Mich. (PRWEB) March 25, 2019 Please join twenty thousand Meniere’s patients that have been helped since the Journal of Upper Cervical Chiropractic Research published "Health Outcomes Foll...

Machine Treating Patients? It’s Already Happening

(TIME) – Mabu is among the latest examples of what machine learning, or artificial intelligence (AI), can accomplish in medicine. The questions she asks come from a recipe that combines best practices that doctors use to monitor heart-failure patients like … Read More

Veracyte Announces New Afirma Xpression Atlas Data that Advance Genomic Understanding of Medullary Thyroid Cancer

Findings Presented at ENDO 2019 Conference Veracyte, Inc. (Nasdaq: VCYT) announced today that new data from the Afirma® Xpression Atlas suggest that the majority of newly diagnosed medullary thyroid cancers (MTC) are associated with variants from three genes. The findings shed new light on the genomic underpinning of this rare, but aggressive, ...

Early AVR bests ‘watchful waiting’ in asymptomatic patients

AVLT and UKTS Announce the European Medicines Agency’s Approval of the Conditional Marketing Authorization Application for Zynteglo™ (Previously Known as Lentiglobin™) Gene Therapy for the Treatment of Transfusion Dependent Beta Thalassaemia

- The European Medicines Agency Human Medicines Committee (CHMP) has approved a Conditional Marketing Authorisation in the European Union for Zynteglo™ Associaz

Physicians’ Education Resource® Presents “Cutting CVD Risk by Adding PCSK9 Inhibitors: What the Internist Needs to Know”

This live symposium will be held adjunct to the 2019 American College of Physicians Internal Medicine Meeting Physicians’ Education Resource® (PER®), a worldwide leader in continuing medical education (CME), will conduct a live CME-accredited activity, “Cutting CVD Risk by Adding PCSK9 Inhibitors: What the Internist Needs to Know,” as a satelli...

FDA committee considers neuroAD therapy system to treat Alzheimer’s disease

Neuronix said that the neuroAD Therapy System is presently approved and is being sold across Europe, Australia and Israel. In the US, though it still remains as investigational The post FDA committee considers neuroAD therapy system to treat Alzheimer’s disease appeared first on Compelo Medical Devices - Latest industry news and analysis.

New IR treatment helps patients suffering from ‘tennis elbow’ without surgery

Moskowitz Weighs Benefits, Challenges With A+AVD in Hodgkin Lymphoma

Craig Moskowitz, MD, discusses the role of PET imaging in the treatment of patients with Hodgkin lymphoma, weighs the pros and cons of A+AVD, and speaks to where future research is headed in the space.

FDA authorises Jazz Pharma's sleep disorder therapy Sunosi http://bit.ly/2TPNYy8  #pharma

FDA authorises Jazz Pharma's sleep disorder therapy Sunosi http://bit.ly/2TPNYy8  #pharma

STAT Plus: Thermo Fisher gets into gene therapy with $1.7B deal for Brammer Bio

Thermo Fisher is buying Brammer Bio makes, which makes viral vectors to deliver genetic material into defective cells to treat an inherited disorder.

Shares in Proteostasis Therapeutics plunge on disappointing results for cystic fibrosis triplet therapy https://www.firstwordpharma.com/node/1631157?tsid=28®ion_id=6 …

Shares in Proteostasis Therapeutics plunge on disappointing results for cystic fibrosis triplet therapy https://www.firstwordpharma.com/node/1631157?tsid=28&region_id=6 …

FDA Approves Impulse Dynamics’ Optimizer Smart For Heart Failure As Breakthrough Device

The Optimizer Smart implantable pulse generator delivers Cardiac Contractility Modulation therapy to improve the quality of life and functional status...   

Gelesis Presents Expanded Data Showing Impact of Gelesis100 Hydrogel on Patients with Prediabetes, Untreated Diabetes, and Elevated Insulin Resistance

Individuals with prediabetes and those with untreated type 2 diabetes had six times higher odds to achieve ≥10% weight loss compared to placebo Individuals with high insulin resistance achieved significant drop in HOMA-IR levels on treatment independent of their level of weight loss Geles

NantHealth to Report 2018 Fourth-Quarter Financial Results and Host Conference Call on Thursday, March 28

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 fourth quarter on Thursday, March 28, 2019, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s perf...

Lead Glasses Offer 'False Sense of Security' Against Radiation

(MedPage Today) -- Study reinforces need to take all safety measures possible

These chatbots are designed to help manage diabetes or figure out a headache. The companies weren't prepared for patients typing in their suicidal thoughts. By @RebeccaDRobbins: https://www.statnews.com/2019/03/25/patients-suicidal-thoughts-digital-healt

These chatbots are designed to help manage diabetes or figure out a headache. The companies weren't prepared for patients typing in their suicidal thoughts. By @RebeccaDRobbins: https://www.statnews.com/2019/03/25/patients-suicidal-thoughts-digital-health-apps-response/ …


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks